Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MYRIAD GENETICS INC Director's Dealing 2010

Jan 14, 2010

32566_dirs_2010-01-14_3517ea1d-f51a-4072-a6e8-3954f6379301.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2009-12-03

Reporting Person: MARSH RICHARD M (V.P., General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-10-30 Common Stock G 300 Disposed 18678 Direct
2009-12-03 Common Stock G 4200 Disposed 14808 Direct
2010-01-12 Common Stock M 9726 $7.27 Acquired 24534 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-01-12 Incentive Stock Option (right to buy) $7.27 M 9726 Disposed 2015-09-14 Common Stock (9726) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 8000 Indirect

Footnotes

F1: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.